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The Rho1 effector Pkc1, but not Bni1, mediates signalling from
Tor2 to the actin cytoskeleton
Stephen B. Helliwell*†, Anja Schmidt*, Yoshikazu Ohya‡ and Michael N. Hall*
In Saccharomyces cerevisiae, the phosphatidylinositol
kinase homologue Tor2 controls the cell-cycle-
dependent organisation of the actin cytoskeleton by
activating the small GTPase Rho1 via the exchange
factor Rom2 [1,2]. Four Rho1 effectors are known,
protein kinase C 1 (Pkc1), the formin-family protein
Bni1, the glucan synthase Fks and the signalling protein
Skn7 [2,3]. Rho1 has been suggested to signal to the
actin cytoskeleton via Bni1 and Pkc1; rho1 mutants
have never been shown to have defects in actin
organisation, however [2,4]. We have further
investigated the role of Rho1 in controlling actin
organisation and have analysed which of the Rho1
effectors mediates Tor2 signalling to the actin
cytoskeleton. We show that some, but not all, rho1
temperature-sensitive (rho1ts) mutants arrest growth
with a disorganised actin cytoskeleton. Both the growth
defect and the actin organisation defect of the rho1-2ts
mutant were suppressed by upregulation of Pkc1 but
not by upregulation of Bni1, Fks or Skn7.
Overexpression of Pkc1, but not overexpression of
Bni1, Fks or Skn7, also rescued a tor2ts mutant, and
deletion of BNI1 or SKN7 did not prevent the
suppression of the tor2ts mutation by overexpressed
Rom2. Furthermore, overexpression of the Pkc1-
controlled mitogen-activated protein (MAP) kinase
Mpk1 suppressed the actin defect of tor2ts and rho1-2ts
mutants. Thus, Tor2 signals to the actin cytoskeleton via
Rho1, Pkc1 and the cell integrity MAP kinase cascade.
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Results and discussion
To investigate whether Rho1 has a role in the control of
the actin cytoskeleton, we examined the actin cytoskeleton
in four previously isolated rho1 temperature-sensitive
mutants [5]. Rho1 wild-type cells (YOC784) and rho1-2ts
(YOC772), rho1-3ts (YOC773), rho1-4ts (YOC774), and rho1-
5ts (YOC776) mutant cells were grown at the permissive
temperature (24°C), shifted to the non-permissive temper-
ature (37°C) for 5 hours, and processed for visualisation of
the actin cytoskeleton (Figure 1). The rho1-3ts and rho1-4ts
cells arrested growth as cells with small buds and with a
normal distribution of actin, as described previously for
rho1 mutants [4]. In contrast, rho1-2ts and rho1-5ts cells
arrested growth and had a completely random distribution
of actin. These results demonstrate that Rho1 is required
for polarisation of the actin cytoskeleton.
The direct effector molecules of Rho1 are Pkc1, the
nonessential formin-family protein Bni1, the redundant
Fks1 and Fks2 proteins (glucan synthases), and the
nonessential two-component signalling protein Skn7 [2,3].
We examined whether overexpression or activation of any
one of these Rho1 effector molecules could suppress the
growth defect associated with the different rho1 mutations.
Plasmids overexpressing Pkc1 (pPKC1), Bni1 (pBNI1),
Fks1 (pFKS1), Fks2 (pFKS2) or Skn7 (pSKN7), and a
plasmid expressing activated Pkc1 (pPKC1*) were trans-
formed into the four rho1ts mutants described above, and
transformants were monitored for growth at high tempera-
ture (Figure 2a and data not shown). The rho1-2ts and rho1-
5ts mutants, which are defective in actin organisation, were
rescued by activated Pkc1, and the rho1-5ts mutant was also
rescued by the overexpression of wild-type Pkc1 [6]. Over-
expression of Bni1, Fks1, Fks2 or Skn7 did not suppress
the growth defect of this class of rho1 mutant. The growth
defect of the rho1-3ts and rho1-4ts mutants was not sup-
pressed by any of the plasmids used in this experiment
(data not shown). Thus, the growth defect of rho1 mutants
defective in actin organisation is suppressed by upregula-
tion of Pkc1, but not by upregulation of Bni1, Fks or Skn7.
We next examined the actin cytoskeleton in rho1-2ts cells
containing pPKC1*, pBNI1, pFKS1, pFKS2 or pSKN7
(Figure 2b). Upregulation of Pkc1 suppressed the actin
defect of the rho1-2ts mutant, whereas the other Rho1 effec-
tors Bni1, Fks1, Fks2 or Skn7 did not restore actin polarisa-
tion. Thus, rho1-2ts is defective primarily in activating Pkc1
and in signalling to the actin cytoskeleton, which suggests
that Rho1 signals to the actin cytoskeleton via Pkc1. 
We have shown previously that tor2ts mutants are defec-
tive in actin organisation and that Tor2 activates Rho1
[1,7]. To examine further if Pkc1 mediates Rho1 
signalling to the actin cytoskeleton, we asked whether
upregulation of Pkc1, Bni1, Fks1, Fks2 or Skn7 could sup-
press a tor2ts mutation. Plasmids pPKC1, pPKC1*, pBNI1,
pFKS1, pFKS2 and pSKN7 were transformed into a tor2ts
mutant (SH121), and transformants were assayed for
growth at high temperature. The tor2ts cells containing
pPKC1 or pPKC1* grew almost like wild-type cells (see
Supplementary material published with this paper on the
internet) [8]. Overexpression of Pkc1 also suppressed,
albeit weakly, the actin organisation defect of the tor2ts
mutant (data not shown). The tor2ts cells containing
pFKS1, pFKS2, pBNI1 or pSKN7 were not viable at high
temperature. The finding that upregulation specifically of
Pkc1 suppressed a tor2ts mutation suggests that Tor2
signals to the actin cytoskeleton via Pkc1. 
The above data do not exclude the possibility that Fks,
Bni1 or Skn7 are also involved in Tor2-mediated signalling
to the actin cytoskeleton. It is unlikely, however, that Fks
is involved because Fks is the catalytic subunit of glucan
synthase, and loss of Fks1 suppresses the growth defect of
a tor2ts mutant [9]. We examined further whether Bni1 or
Skn7 could be involved in signalling from Tor2 to actin.
We have shown previously that Tor2 activates Rho1 via
the exchange factor Rom2 and that overexpression of
Rom2 suppresses a tor2ts mutation [1]. If Tor2 signals to
the actin cytoskeleton via Bni1 or Skn7, deletion of BNI1
or SKN7 should, at least partly, prevent suppression of the
tor2ts mutant by Rom2 overexpression (pROM2). Double
mutant strains bni1 tor2ts (AS168) and skn7 tor2ts (SH122-
10a) were transformed with pROM2 and monitored for
growth at high temperature. Overexpression of Rom2 sup-
pressed the growth defect of the bni1 tor2ts and skn7 tor2ts
cells as effectively as it suppressed the growth defect of a
tor2ts mutant containing intact BNI1 and SKN7, suggesting
that Bni1 and Skn7 are not required for signalling from
Tor2 to actin. The above results taken together suggest
that Tor2-activated Rho1 signals to the actin cytoskeleton
mainly, if not exclusively, via Pkc1.
The only known signalling pathway downstream of Pkc1
is a MAP kinase cascade [10,11] that maintains cell wall
integrity and might also control the actin cytoskeleton
[12–14]. Our findings suggest that the MAP kinase
cascade is also involved in signalling to the actin
cytoskeleton. To investigate if the MAP kinase cascade is
indeed involved in Tor2 and Pkc1 signalling to the actin
cytoskeleton, we examined if upregulation of the MAP
kinase pathway suppressed a tor2ts mutation. The compo-
nents of the cascade are Bck1 (a MAP kinase kinase
kinase or MEKK), Mkk1 and Mkk2 (redundant MAP
kinase kinases or MEKs), and Mpk1 (a MAP kinase). A
tor2ts mutant (SH121) was transformed with a low copy
plasmid containing activated Bck1 (pBCK1-20) and with
multicopy plasmids bearing MKK1 (pMKK1) or MPK1
(pMPK1), and assessed for growth at high temperature.
Upregulation of the Pkc1 MAP kinase cascade at any level
suppressed the growth defect of the tor2ts mutant (see
Supplementary material). Furthermore, overexpression of
Mpk1 also suppressed the actin organisation defect of the
tor2ts strain (data not shown). We also examined if over-
expression of Mpk1 suppressed the rho1-2ts mutant. Over-
expression of the MAP kinase did not suppress the growth
defect of the rho1-2ts mutant (Figure 2a), but the actin
cytoskeleton was clearly better polarised in these cells
when compared with cells not overexpressing Mpk1
(Figure 2b). The finding that upregulation of Pkc1 or
Mpk1 suppressed the actin defect of the rho1-2ts mutant,
but only Pkc1 suppressed the lethality of this mutant, sug-
gests that there is a bifurcation below Pkc1, as proposed
previously [10], and that at least the MAP kinase branch
signals to the actin cytoskeleton. The above results taken
together suggest that Pkc1 signals to the actin cytoskele-
ton via the MAP kinase cascade.
We have established previously that Tor2 activates Rho1
via the GDP/GTP exchange factor Rom2, and that tor2ts
mutants have defects in actin organisation [1,7]. Here, we
have investigated the role of Rho1 and downstream 
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Figure 1
Rho1 is required for organisation of the actin
cytoskeleton. The rho1-2ts and rho1-5ts cells
are defective for correct actin distribution,
whereas rho1-3ts and rho1-4ts cells have a
normal actin distribution. RHO1 wild-type and
rho1-2ts, rho1-3ts, rho1-4ts and rho1-5ts
mutant cells were grown at 24°C, shifted to
37°C for 5 h, fixed, stained with
TRITC–phalloidin to visualise the actin
cytoskeleton and observed by fluorescence
(top row) or Nomarski microscopy (bottom
row), as described [7]. Strains are as follows:
RHO1 is YOC784, rho1-2 is YOC772,
rho1-3 is YOC773, rho1-4 is YOC774, and
rho1-5 is YOC776.
rho1-2 rho1-3 rho1-4
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components in the regulation of the actin cytoskeleton.
We show that some, but not all, rho1ts strains have a severe
actin organisation defect, indicating that Rho1 indeed con-
trols the actin cytoskeleton. We then show that, of all the
Rho1 direct effectors (Pkc1, Bni1, Fks and Skn7), upregu-
lation only of Pkc1 rescues tor2 and rho1 mutants defec-
tive in actin organisation. This suggests that Tor2 and
Rho1 signal to the actin cytoskeleton mainly, if not exclu-
sively, via Pkc1. Finally, looking further downstream, we
demonstrate that overexpression of the Pkc1-controlled
MAP kinase Mpk1 suppresses the actin defect of tor2 and
rho1 mutants, suggesting that Tor2, Rho1 and Pkc1 signal
to the actin cytoskeleton via the cell integrity MAP kinase
cascade. A model summarising our findings is shown in
the Supplementary material.
The cell integrity MAP kinase cascade maintains cell
integrity by activating the transcription of genes required
for cell wall synthesis [12,13]. It remains to be determined
whether the MAP kinase cascade also controls the actin
cytoskeleton via gene transcription. Alternatively, the
MAP kinase cascade may control the actin cytoskeleton
more directly.
Two lines of reasoning suggest that Tor2 activates only a
select subset of Rho1 molecules involved in actin organi-
sation. First, cells lacking Tor2 have a different terminal
phenotype compared with cells lacking Rho1. The tor2
cells have a randomised actin cytoskeleton whereas rho1-
null cells, in contrast to rho1-2ts and tor2 cells, arrest
growth with a cell wall defect but a polarised actin
cytoskeleton [4,7,8]. A rho1-null mutant presumably dies
of a cell wall defect before the actin cytoskeleton becomes
randomly distributed. A tor2 mutation does not confer a
detectable cell wall defect (S.B.H., unpublished observa-
tions) and is even suppressed by such a defect [9]. This
suggests that Tor2 does not activate the pool of Rho1 that
regulates the cell wall synthesis enzyme glucan synthase.
This pool of Rho1 may be activated by a separate input
independently of Tor2 [9]. Second, Bni1 appears to be
neither necessary nor sufficient for Tor2 signalling. The
notion that Tor2 could be signalling through only a subset
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Figure 2
Rho1 signals to the actin cytoskeleton via
Pkc1 and Mpk1. (a) Upregulation of Pkc1
(Pkc1*), but not Bni1, Fks1, Skn7 or Mpk1
rescues the rho1-2ts mutant. The rho1-2ts
mutant (YOC772) was transformed with
pPKC1*, pBNI1, pFKS1, pSKN7, pMPK1 or
empty vector (see Supplementary material)
and transformants were incubated on rich
medium (YPD) at 24°C or 37°C for 3 days.
RHO1 wild-type cells were also plated. The
composition of the YPD was as described
[17]. (b) Upregulation of Pkc1 (Pkc1*) and
Mpk1, but not Bni1, Fks1 or Skn7,
suppresses the actin defect of the rho1-2ts
mutant (YOC772). The transformants
described in (a) and the wild-type RHO1
strain were assessed for the state of their
actin 3.5 h after a shift to the nonpermissive
temperature (37°C). The cells were treated for
fluorescence (left panels) or Nomarski






























of Rho1 effectors is similar to that suggested for activation
of the GTPase Rac by phosphatidylinositol (PI) 3-kinase
in mammalian cells. Reif et al. [15] have shown that consti-
tutively activated PI 3-kinase induces Rac/Rho-depen-
dent cytoskeletal rearrangements but does not stimulate
the Rac or Rho signalling pathways that regulate gene
transcription. How a selective activation of Rho1 is
achieved remains to be determined.
Contrary to expectations, we have been unable to detect a
reduction in Mpk1 kinase activity in a tor2ts mutant
shifted to high temperature (D. Levin and M.N.H.,
unpublished observations). This may be because the
existing assay for Mpk1 activity measures only the
enhancement of Mpk1 activity that occurs in response to
heat or osmotic stress [16], and Tor2 may control only the
basal level of the cascade. The stress induction of the
MAP kinase cascade may be controlled independently of
Tor2, as suggested previously [9].
Supplementary material
Two figures showing that overexpression of Pkc1 or the Pkc1-con-
trolled MAP kinase cascade suppresses a tor2ts mutation, a model for
actin regulation by Tor2, and tables of the yeast strains and plasmids
used in this study are published with this paper on the internet.
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Overexpression of PKC1* but not of FKS1, BNI1 or SKN7 suppresses a tor2ts mutation. Wild-type TOR2 (JK9-3da) cells and tor2ts (SH121) cells
carrying an empty vector or pPKC1*, pBNI1, pFKS1 or pSKN7 were incubated on rich medium (YPD) at 30°C or 37°C for 3 days. 
Figure S2
Upregulation of the Pkc1-controlled MAP
kinase cascade rescues a tor2ts mutant. Wild-
type TOR2 cells and tor2ts (SH121) cells
carrying empty vector, pTOR2, pPKC1,
pBCK1-20, pMKK1 or pMPK1 were
incubated on rich medium (YPD) at 30°C or
37°C for 3 days.

























Yeast strains used in this study.
Strain Genotype
JK9-3da MATa leu2-3,112 ura3-52 trp1 his4 rme1 HMLa
JK9-3dα MATα leu2-3,112 ura3-52 trp1 his4 rme1 HMLa
AS168 JK9-3da tor2::ADE2 bni1::URA3 ade2 / 
YCplac111::tor2-21ts
NB67-10a JK9-3dα skn7::URA3 ade2 his3 HIS4
SH121 JK9-3da tor2::ADE2 ade2 / YCplac111::tor2-21ts
SH122-10a JK9-3da tor2::ADE2 skn7::URA3 ade2 HIS4 / 
YCplac111::tor2-21ts
YOC784 MATa ade2 his3 leu2 lys2 trp1 rho1::HIS3 ade3::[RHO1
LEU2]
YOC772 MATa ade2 his3 leu2 lys2 trp1 rho1::HIS3 ade3::[rho1-2
LEU2]
YOC773 MATa ade2 his3 leu2 lys2 trp1 rho1::HIS3 ade3::[rho1-3
LEU2]
YOC774 MATa ade2 his3 leu2 lys2 trp1 rho1::HIS3 ade3::[rho1-4
LEU2]
YOC776 MATa ade2 his3 leu2 lys2 trp1 rho1::HIS3 ade3::[rho1-5
LEU2]
Table S2
Plasmids used in this study.
Plasmid Description
pPKC1 pSH24, pSEY18::PKC1 (2µ, URA3) 
pPKC1* YCp50::PKC1R398P (CEN, URA3) 
pBNI1 YEp24::BNI1 (2µ, URA3) 
pFKS1 pPAD33, YEplac195::FKS1 (2µ, URA3)
pFKS2 pFF336, YCplac33::ADH1-FKS2 (CEN URA3 
ADH1 promoter)
pSKN7 pNB82, YEplac195::SKN7 (2µ, URA3)
pRHO2 pAS38, YEplac112::RHO2 (2µ, TRP1)
pROM2 pAS50, YEplac112::ROM2 (2µ, TRP1)
pBCK1-20 pRS352::BCK1-20 (2µ, URA3)
pMKK1 YEp352::MKK1 (2µ, URA3) 
pMPK1 YEp352::MPK1 (2µ URA3)
Figure S3
Model for actin regulation by Tor2. Red arrows indicate the pathway
through which Tor2 signals to the actin cytoskeleton. See main text for
details. Our data suggest that Tor2-activated Rho1 does not signal to
actin via Bni1; however, Rho1 activated by some other input may still
signal to actin via Bni1. 
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